| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |